SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005818
Filing Date
2016-05-10
Accepted
2016-05-10 16:36:27
Documents
54
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20160331x10q.htm 10-Q 1417578
2 EX-10.1 bpmc-20160331ex101b50b7b.htm EX-10.1 1015451
3 EX-10.2 bpmc-20160331ex102971a3b.htm EX-10.2 1695124
4 EX-31.1 bpmc-20160331ex311ce6cae.htm EX-31.1 17915
5 EX-31.2 bpmc-20160331ex312177965.htm EX-31.2 17970
6 EX-32.1 bpmc-20160331ex3218276c9.htm EX-32.1 13656
  Complete submission text file 0001558370-16-005818.txt   7565019

Data Files

Seq Description Document Type Size
7 EX-101.INS bpmc-20160331.xml EX-101.INS 846869
8 EX-101.SCH bpmc-20160331.xsd EX-101.SCH 40524
9 EX-101.CAL bpmc-20160331_cal.xml EX-101.CAL 42742
10 EX-101.DEF bpmc-20160331_def.xml EX-101.DEF 153695
11 EX-101.LAB bpmc-20160331_lab.xml EX-101.LAB 412444
12 EX-101.PRE bpmc-20160331_pre.xml EX-101.PRE 274241
Mailing Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139
Business Address 38 SIDNEY STREET, SUITE 200 CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 161636290
SIC: 2834 Pharmaceutical Preparations